ꢂꢁꢁꢁ
Y. B. Ivanova et al.: New heterocyclic chalconesꢀ
ꢀ27
7.26 (d, 1H, arom H, J = 8.2 Hz); 7.70 (d 1H, =CHCO, J = 15.5 Hz); 7.92 7.75 (d, 1H, arom H, J = 1.7 Hz); 7.91 (d, 1H, ArCH=, J = 15.5 Hz); 8.05
(d, 1H, ArCH=, J = 15.5 Hz); 8.08 (dd, 1H, arom H, J1 = 8.2 Hz, J2 = 1.5 Hz); (dd, 1H, arom H, J1 = 8.4 Hz, J2 = 1.7 Hz); 13C NMR: 56.0, 60.0, 106.4,
8.12 (d, 1H, arom H, J = 1.5 Hz); 12.09 (br s, 1H, NH); 13C NMR: 56.1, 109.4, 120.9, 123.9, 130.1, 130.9, 133.7, 133.7, 139.7, 144.4, 146.7, 153.0,
60.1, 106.5, 109.5, 120.8, 125.6, 130.2, 131.9, 134.9, 139.6, 143.4, 144.2, 154.2, 187.7. Anal. Calcd for C19H17NO6: C, 64.22; H, 4.82; N, 3.94. Found:
153.0, 154.4, 187.1. Anal. Calcd for C19H17NO6: C, 64.22; H, 4.82; N, 3.94. C, 64.33; H, 4.61; N, 3.94.
Found: C, 64.51; H, 5.05; N, 4.24.
5-[3-(2-Methoxyphenyl)-2-propenoyl]-2(3Н)-benzoxazolone (3g)
Biological activities
Yield 93%; mp 199–201°C; IR: 1790, 1643 (C=O) cm-1; 1Н NMR: δ 3.90 (s,
3H, OCH3); 7.04 (m, 1H, arom H); 7.12 (d, 1H, arom H, J = 7.9); 7.45 (dd,
2H, arom H, J1 = 8.4, J2 = 1.9 Hz) 7.74 (d, 1H, arom H, J = 1.7 Hz); 7.89 (d,
1H, =CHCO, J = 15.7 Hz); 7.99 (dd, 2H, arom H, J1 = 8.4 Hz, J2 = 1.7 Hz);
8.06 (d, 1H, ArCH=, J = 15.7 Hz); 11.94 (br s, 1H, NH); 13C NMR: 55.7,
109.3, 109.4, 111.7, 120.6, 121.6, 123.8, 128.5, 130.9, 132.3, 133.7, 138.4,
146.7, 146.7, 158.2, 158.2, 187.8. Anal. Calcd for C17H13NO4: C, 69.15; H,
4.44; N, 4.74. Found: C, 69.36; H, 4.57; N, 4.79.
Cytotoxic activity (MTT-dye reduction assay)
The cytotoxic activity of the tested compounds was
assessed by the MTT-dye reduction assay as described by
Mosmann, with minor modifications [22]. Briefly, expo-
nentially growing cells were seeded into 96-well plates
(100 μL aliquots/well at a density of 1 × 105 cells/mL).
Following a 24-h adaptation period, they were exposed
to various concentrations of the tested compounds for
72 h. After the treatment period, MTT solution (10 mg/mL
in PBS) was added (10 μL/well). Plates were further
incubated for 4 h at 37°C and the MTT-formazan crys-
5-[3-(3-Methoxyphenyl)-2-propenoyl]-2(3Н)-benzoxazolone (3h)
1
Yield 95%; mp 180–181°C; IR: 1785, 1657 (C=O) cm-1; Н NMR: δ 3.84
(s, 3H, OCH3); 7.03 (m, 1H, arom H); 7.44–7.49 (m, 3H, arom H); 7.72
(d, 1H, =CHCO, J = 15.5 Hz); 7.77 (d, 1H, arom H, J = 1.7 Hz) 7.97 (d,
1H, ArCH=, J = 15.5 Hz); 8.05 (dd, 1H, arom H, J1 = 8.4 Hz, J2 = 1.7 Hz);
11.95 (br s, 1H, NH); 13C NMR: 55.2, 109.3, 113.4, 116.6, 121.6, 122.1, 123.9,
129.8, 130.9, 133.6, 135.9, 143.9, 146.8, 154.2, 159.5, 159.6, 187.8. Anal.
Calcd for C17H13NO4: C, 69.15; H, 4.44; N, 4.74. Found: C, 68.86; H, 4.28; tals formed were dissolved by adding 100 μL/well of 5%
N, 4.88.
formic acid in 2-propanol. Absorption was measured on
an ELISA reader (Uniscan® Titertek, Helsinki, Finland)
5-[3-(4-Methoxyphenyl)-2-propenoyl]-2(3Н)-benzoxazolone (3i)
at 540 nm. For each concentration at least eight wells
Yield 81%; mp 222–225°C; IR: 1771, 1650 (C=O) cm-1; 1Н NMR: δ 3.82 (s,
3H, OCH3); 7.01–7.03 (m, 2H, arom H); 7.44 (d, 1H, arom H, J = 8.4 Hz);
7.71 (d, 1H, =CHCO, J = 15.5 Hz); 7.74–7.79 (m, 2H, arom H, ArCH=); 7.86
(d, 2H, arom H, J = 7.2 Hz); 8.01 (d, 1H, arom H, J = 8.4 Hz); 11.93 (br
s, 1H, NH); 13C NMR: 55.3, 109.2, 109.3, 114.3, 114.3, 119.2, 123.7, 127.2,
130.7, 130.8, 130.9, 133.9, 143.9, 146.6, 154.2, 161.3, 187.6. Anal. Calcd for
C17H13NO4: C, 69.15; H, 4.44; N, 4.74. Found: C, 69.55; H, 4.56; N, 4.62.
were used. A mixture of 100 μL RPMI-1640 medium with
10 μL MTT stock and 100 μL 5% formic acid in 2-propa-
nol served as a blank solution. The cell viability (% of
untreated control) for each treatment group was calcu-
lated using the formula:
AT
% of untreated control= ×100
AC
5-[3-(2,4-Dimethoxyphenyl)-2-propenoyl]-2(3Н)-benzoxazolone
1
(3j)ꢀYield 85%; mp 239–243°C; IR: 1793, 1635 (C=O) cm-1; Н NMR:
δ 3.90 (s, 9H, OCH3); 6.60–6.67 (m, 2H, arom H); 7.43 (d, 1H, arom H,
J = 8.4 Hz); 7.71 (d, 1H, arom H, J = 1.4 Hz); 7.76 (d, 1H, =CHCO, J =
15.6 Hz); 7.91–8.02 (m, 3H, arom H, ArCH=); 11.91 (br s, 1H, NH); 13C
NMR: 55.5, 55.8, 98.2, 98.2, 106.3, 109.1, 109.3, 115.8, 118.7, 123.5, 130.0,
130.8, 134.1, 138.6, 146.5, 159.9, 163.0, 187.8. Anal. Calcd for C18H15NO5:
C, 66.46; H, 4.65; N, 4.31. Found: C, 66.52; H, 4.29; N, 4.47.
where AT denotes MTT-formazan absorption of the test
sample and AC denotes MTT-formazan absorption of the
control (solvent treated) sample.
Concentration response curves were generated and
the corresponding IC50 values were extrapolated using
Origin plot Software for PC.
5-[3-(3,4-Dimethoxyphenyl)-2-propenoyl]-2(3Н)-benzoxazolone
1
(3k)ꢀYield 88%; mp 208–210°C; IR: 1785, 1664 (C=O) cm-1; Н NMR:
δ 3.82 (s, 3H, OCH3); 3.87 (s, 3H, OCH3); 7.03 (d, 1H, arom H, J = 8.4 Hz);
7.40 (dd, 1H, arom H, J1 = 8.4, J2 = 2.0 Hz); 7.46 (d, 1H, arom H, J = 8.4
Hz); 7.55 (d, 1H, arom H, J = 2.0 Hz); 7.70 (d, 1H, =CHCO, J = 15.4 Hz);
7.75 (d, 1H, arom H, J = 1.8 Hz); 7.84 (d, 1H, ArCH=, J = 15.4 Hz); 8.03
(dd, 1H, arom H, J1 = 8.4 Hz, J2 = 1.8 Hz); 13C NMR: 55.6, 109.2, 110.7,
111.4, 119.3, 123.7, 123.9, 127.3, 130.8, 133.8, 142.6, 144.4, 145.7, 146.6,
148.9, 151.2, 154.2, 187.7. Anal. Calcd for C18H15NO5: C, 66.46; H, 4.65; N,
4.31. Found: C, 66.70; H, 4.78; N, 4.07.
Cell-death detection
The characteristic for apoptosis oligonucleosomal DNA
fragmentation was examined using a commercially
available ‘cell death detection’ ELISA kit (Roche Applied
Science). This method allows semiquantitative deter-
mination of the characteristic for the apoptotic process
of histone-associated mono- and oligonucleosomal
DNA fragments using ‘sandwich’ ELISA. Exponentially
5-[3-(3,4,5-Trimethoxyphenyl)-2-propenoyl]-2(3Н)-benzo-
xazolone (3l)ꢀYield 98%; mp 210–212°C; IR: 1771, 1657 (C=O) cm-1;
1Н NMR: δ 3.73 (s, 3H, OCH3); 3.87 (s, 6H, OCH3); 7.23–7.26 (m, 2H, arom
H); 7.48 (d, 1H, arom H, J = 8.4 Hz); 7.70 (d, 1H, =CHCO, J = 15.5 Hz); growing cells were exposed to varying concentrations of